Nuvation Bio Inc. (NUVB): Price and Financial Metrics
NUVB Price/Volume Stats
| Current price | $2.62 | 52-week high | $4.16 |
| Prev. close | $2.66 | 52-week low | $0.95 |
| Day low | $2.53 | Volume | 642,500 |
| Day high | $2.65 | Avg. volume | 1,189,378 |
| 50-day MA | $2.53 | Dividend yield | N/A |
| 200-day MA | $1.75 | Market Cap | 571.28M |
NUVB Stock Price Chart Interactive Chart >
Nuvation Bio Inc. (NUVB) Company Bio
Nuvation Bio Inc. operates as a bio-pharmaceutical company. The Company focuses on developing oncology medicines that will improve patient lives by addressing drug resistance. Nuvation Bio serves patients worldwide.
Latest NUVB News From Around the Web
Below are the latest news stories about NUVATION BIO INC that investors may wish to consider to help them evaluate NUVB as an investment opportunity.
Companies Like Nuvation Bio (NYSE:NUVB) Are In A Position To Invest In GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
Nuvation Bio Announces Departure of Chief Financial OfficerNEW YORK, November 13, 2023--Nuvation Bio Inc. (NYSE: NUVB) (the "Company") announced today that Jennifer Fox will be stepping down from her role as Chief Financial Officer to pursue a new opportunity. Ms. Fox has advised the Company that she is seeking later stage development and commercial launch experience as part of her career development and that she is leaving with a high regard for the Company, its leadership and its financial state. Ms. Fox submitted her resignation on November 9, 2023 w |
Nuvation Bio Inc (NUVB) Reports Q3 2023 Financial ResultsCompany's cash and marketable securities stand at $619.3 million as of Q3 2023, with a net loss of $19.6 million |
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNEW YORK, November 02, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the third quarter ended September 30, 2023, and provided a business update. |
One Nuvation Bio Insider Raised Their Stake In The Previous YearInsiders were net buyers of Nuvation Bio Inc.'s ( NYSE:NUVB ) stock during the past year. That is, insiders bought more... |
NUVB Price Returns
| 1-mo | -9.03% |
| 3-mo | 52.33% |
| 6-mo | 156.86% |
| 1-year | 59.76% |
| 3-year | -76.86% |
| 5-year | N/A |
| YTD | 73.51% |
| 2023 | -21.35% |
| 2022 | -77.41% |
| 2021 | -27.35% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...